Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients With EGFR-mutant, Locally Advanced or Metastatic/Recurrent Non-Small Cell Lung Cancer (INSTAR Study)
Clinical trial NCT07507188 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07507188
- Sponsor
- Yonsei University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-06
- Primary completion
- 2031-01-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.